Literature DB >> 31812831

Recent progress in the development of organometallics for the treatment of cancer.

Benjamin S Murray1, Paul J Dyson2.   

Abstract

From their early successes in medicine, organometallic compounds continue to attract interest as potential chemotherapeutics to treat a range of diseases. Here, we show from recent literature selected largely from the last two years that organometallics offer unique opportunities in medicine and, increasingly, a mechanistic-based approach is applied to their development, which has not always been the case.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bioinorganic chemistry; Bioorganometallic chemistry; Chemotherapy; Metallodrugs

Mesh：

Substances：

Year:  2019        PMID： 31812831     DOI： 10.1016/j.cbpa.2019.11.001

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN： 1367-5931            Impact factor:   8.822


  12 in total

Review 1.  Target-specific mononuclear and binuclear rhenium(i) tricarbonyl complexes as upcoming anticancer drugs.

Authors:  Ajay Sharma S; Vaibhavi N; Binoy Kar; Utpal Das; Priyankar Paira
Journal:  RSC Adv       Date:  2022-07-14       Impact factor: 4.036

2.  Metalloimmunotherapy with Rhodium and Ruthenium Complexes: Targeting Tumor-Associated Macrophages.

Authors:  Nicholas Toupin; Mackenzie K Herroon; Randolph P Thummel; Claudia Turro; Izabela Podgorski; Heather Gibson; Jeremy J Kodanko
Journal:  Chemistry       Date:  2022-03-24       Impact factor: 5.020

3.  The Application of Reversible Intramolecular Sulfonamide Ligation to Modulate Reactivity in Organometallic Ruthenium(II) Diamine Complexes.

Authors:  Samuel A Kemp; Timothy J Prior; Huguette Savoie; Ross W Boyle; Benjamin S Murray
Journal:  Molecules       Date:  2020-01-07       Impact factor: 4.411

Review 4.  Facing Diseases Caused by Trypanosomatid Parasites: Rational Design of Pd and Pt Complexes With Bioactive Ligands.

Authors:  Dinorah Gambino; Lucía Otero
Journal:  Front Chem       Date:  2022-01-07       Impact factor: 5.221

5.  Tethering Carbohydrates to the Vinyliminium Ligand of Antiproliferative Organometallic Diiron Complexes.

Authors:  Silvia Schoch; Dalila Iacopini; Maria Dalla Pozza; Sebastiano Di Pietro; Ilaria Degano; Gilles Gasser; Valeria Di Bussolo; Fabio Marchetti
Journal:  Organometallics       Date:  2022-02-28       Impact factor: 3.876

6.  Succinimido-Ferrocidiphenol Complexed with Cyclodextrins Inhibits Glioblastoma Tumor Growth In Vitro and In Vivo without Noticeable Adverse Toxicity.

Authors:  Feten Najlaoui; Benoit Busser; Germain Sotoing Taïwe; Pascal Pigeon; Nathalie Sturm; Diane Giovannini; Naziha Marrakchi; Ali Rhouma; Gérard Jaouen; Stéphane Gibaud; Michel De Waard
Journal:  Molecules       Date:  2022-07-21       Impact factor: 4.927

7.  Photoproducts of the Photodynamic Therapy Agent Verteporfin Identified via Laser Interfaced Mass Spectrometry.

Authors:  Chris Furlan; Jacob A Berenbeim; Caroline E H Dessent
Journal:  Molecules       Date:  2020-11-12       Impact factor: 4.411

Review 8.  Rhenium-Based Complexes and in Vivo Testing: A Brief History.

Authors:  Miles S Capper; Hollie Packman; Mark Rehkämper
Journal:  Chembiochem       Date:  2020-04-14       Impact factor: 3.164

9.  Thiourea-Derived Chelating Ligands and Their Organometallic Compounds: Investigations into Their Anticancer Activity.

Authors:  Kelvin K H Tong; Muhammad Hanif; James H Lovett; Katja Hummitzsch; Hugh H Harris; Tilo Söhnel; Stephen M F Jamieson; Christian G Hartinger
Journal:  Molecules       Date:  2020-08-11       Impact factor: 4.411

10.  Selective Anticancer and Antimicrobial Metallodrugs Based on Gold(III) Dithiocarbamate Complexes.

Authors:  Elisa Abás; Diego Aguirre-Ramírez; Mariano Laguna; Laura Grasa
Journal:  Biomedicines       Date:  2021-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.